The therapy marks Roche’s first combination of two monoclonal antibodies administered in a single subcutaneous injection

The collaboration hopes to empower patients to take more control of their own health

The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

A judge has approved a £2m (€2.2m; $2.5m) settlement from the NHS for a five year old girl […]

The American Hospital Association and several other US hospital associations have lost a legal challenge against a proposed […]